CARE Activities
Novel diagnostic approaches in tuberculosis (TB) and multidrug-resistant TB (MDR-TB) and biomarkers of treatment response
Genotypic prediction of tuberculosis drug resistance and implementation of effective MDR-TB management 
HIV molecular epidemiology and new treatment strategies in Russia and Eastern Europe 
Impact of host genomic variation of clinical outcomes in HIV patients
Prioritisation of treatment with direct acting oral anti-HCV drugs (DAA's) in hepatitis C patients
Dissemination, communication and exploitation

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825673.

Subscribe to the CARE newsletter

Francesca Incardona